GH Research Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	78.42	165.96	276.78	5.9	0.5
Short-Term Investments	83.14	0	0	0	0
Cash & Cash Equivalents	161.56	165.96	276.78	5.9	0.5
Cash Growth	-2.65%	-40.04%	4595.10%	1083.73%	-
Other Current Assets	2.53	2.59	3.07	0.02	0.01
Total Current Assets	164.09	168.54	279.84	5.91	0.5
Property, Plant & Equipment	1.07	0.1	0.08	0	0
Long-Term Investments	61.14	85.72	0	0	0
Total Long-Term Assets	62.21	85.82	0.08	0	0
Total Assets	226.3	254.36	279.92	5.91	0.5
Accounts Payable	3.49	1.87	0.88	0	0.09
Current Debt	0.34	0	0	0	0
Other Current Liabilities	2.87	2.68	1.87	0.25	0.01
Total Current Liabilities	6.7	4.55	2.75	0.25	0.1
Long-Term Debt	0.63	0	0	0	0
Total Long-Term Liabilities	0.63	0	0	0	0
Total Liabilities	7.33	4.55	2.75	0.25	0.1
Total Debt	0.97	0	0	0	0
Retained Earnings	-67.94	-32.49	-10.04	-0.84	-0.39
Comprehensive Income	-10.51	-13.04	-5.9	0.2	-0.01
Shareholders' Equity	218.97	249.82	277.18	5.67	0.4
Net Cash / Debt	160.59	165.96	276.78	5.9	0.5
Net Cash / Debt Growth	-3.24%	-40.04%	4595.10%	1083.73%	-
Working Capital	157.39	164	277.09	5.67	0.4
Book Value Per Share	4.21	4.80	5.33	0.12	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).